• CLARA Analytics
• Counterpart
• Empathy
• Federato
• Hyperexponential
• INSTANDA
• OutSystems
• Pinpoint Predictive
• Replicant
• Tremendous
• Upstage

We’ve used generative AI, combined with our proprietary data on these companies and their markets, to create the following scouting reports — in just one click on CB Insights.

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post Book of Scouting Reports: InsurTech NY’s 2025 Spring Conference appeared first on CB Insights Research.

According to CB Insights headcount data, AI firms such as Glean, Scale, and OpenAI have increased their workforce in the country by as much as 67% over the last six months. The country’s domestic AI companies have also seen 32% headcount growth over the same period.

Notably, India is now OpenAI’s second-largest market — with a user base that tripled in the past year — while global tech giants like Microsoft and Nvidia have made substantial infrastructure investments in the country.

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post Global AI race heats up in India with unprecedented hiring spree appeared first on CB Insights Research.

We’ve used generative AI, combined with our proprietary data on these companies and their markets, to create the following scouting reports — in just one click on CB Insights.

CB Insights customers can download the book using the sidebar.

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post Book of Scouting Reports: LSI USA ’25 Emerging Medtech Summit appeared first on CB Insights Research.

Clinical development represents one of pharma’s costliest and riskiest investments.

Trials average $55M each, per a study in JAMA Health Forum, and can take more than a decade to complete. However, over 90% of drugs still fail. AI is emerging as a game-changing force in clinical development, tackling its biggest pain points head-on.

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post AI in clinical trials: How the tech is serving pharma’s riskiest bet appeared first on CB Insights Research.

Now, the strategic question for insurers isn’t whether to adopt generative AI but how quickly.

We’ve developed 6 predictions — informed by CB Insights datasets, including financing and acquisition data, Business Relationships, Earnings Transcripts, and Exit Probability — that we think will guide competitive dynamics over the coming year:

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post Our 6 predictions for the insurance space in 2025 appeared first on CB Insights Research.

Estimates indicate that US hospitals lose $262B annually to revenue cycle inefficiencies, while drugmakers spend more than $1B on average to develop a single drug. Meanwhile, the healthcare workforce in the US faces high burnout and a projected shortage of 124,000 physicians by 2034, according to the Association of American Medical Colleges.

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post The generative AI in healthcare and life sciences market map appeared first on CB Insights Research.

These LLM-based systems mark an evolution beyond copilots: AI agents can accomplish complex tasks on a user’s behalf with minimal intervention, from sales prospecting to compliance decisioning. 

In the rapidly growing landscape for agent infrastructure and applications, over half of companies in the market have been founded since 2023. Meanwhile, funding to startups in the space nearly 3x’d in 2024.

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post What’s next for AI agents? 4 trends to watch in 2025 appeared first on CB Insights Research.

The 2024 Change Healthcare cyberattack demonstrates the far-reaching consequences of cybercrime in healthcare. This attack compromised the protected health information of at least 100M people and cost parent company UnitedHealth around $3B.

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post The cybersecurity in healthcare market map appeared first on CB Insights Research.

But AI and blockchain solutions are driving innovation to create new revenue streams and stoke the existing ones. Early-stage deals in those spaces helped drive a rally in funding and dealmaking in gaming in 2024. Annual funding nearly tripled to $3.2B across 317 deals, with early-stage companies securing 77% of investments — up from 70% in 2023. 

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post AI and Web3 are leading the next wave of gaming innovation appeared first on CB Insights Research.

Rather than full automation, the industry is embracing a more nuanced approach where technology augments human capabilities, creating hybrid workplaces where workers are upskilled to work alongside and manage robotic systems. 

Today’s modular and scalable automation solutions enable incremental modernization, allowing logistics providers to start small, prove ROI, and gradually expand their automated operations while maintaining market adaptability. 

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post The automated warehouse market map appeared first on CB Insights Research.

Open-source AI is drawing unprecedented attention from developers and enterprises, driven in part by DeepSeek’s recent model releases.

Cost pressures and demands to improve the performance of generative AI applications are driving enterprise interest in the ecosystem as organizations seek more flexible and cost-effective alternatives to proprietary solutions. 

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post Should enterprises adopt closed-source or open-source AI models? appeared first on CB Insights Research.

January was a busy month for the generative AI space, headlined by DeepSeek‘s R1 model launch — matching OpenAI’s o1 model capabilities at just 5-10% of the cost, while open-sourcing the technology.

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post This month in genAI: DeepSeek launches R1, OpenAI releases Operator agent, and Nvidia goes on partnership spree appeared first on CB Insights Research.

The AI company, which emerged from Liang Wenfeng’s hedge fund High-Flyer, released an open-source reasoning model (named R1) in January 2025 that rivals the performance of OpenAI’s o1 reasoning model.

DeepSeek says it trained its base model with limited chips and about $5.6M in computing power — a fraction of the $100M+ US rivals have spent training similar models — thanks to some clever techniques.  

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post What DeepSeek’s model releases mean for the future of AI appeared first on CB Insights Research.

US data center power consumption is projected to triple from 25GW in 2024 to over 80GW by 2030. Between 2023 and 2028, data centers could drive nearly half of US electricity growth.

Tech companies are increasingly exploring nuclear energy as a reliable, carbon-free power source to support AI’s exponential growth.

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post Data centers are reshaping nuclear development, driving billions in new power infrastructure investment appeared first on CB Insights Research.

These attacks can inflict damages costing billions of dollars. Since 2017, every critical infrastructure cyberattack causing an estimated $1B+ in damages has affected the healthcare sector in some capacity, highlighting its particular vulnerability to digital threats.

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post Critical infrastructure is under attack: How operational technology (OT) security platforms are helping companies better prepare appeared first on CB Insights Research.

Our experts curated the content below using CBI Instant Insights, a one-click AI analysis and summarization tool. Click on company profiles for more details and sourcing information.

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post This month in genAI: Databricks raises $10B, OpenAI launches Sora, and Google and Apptronik team up on humanoids appeared first on CB Insights Research.

For pharma companies, it’s critical to maximize efficiency in preclinical development — the stage after drug discovery and before clinical trials — as poor processes can mask early warning signs of drug candidates that are likely to fail.

The stakes are high: Studies show that 90% of drugs fail in clinical trials. In Phase 1 trials alone — which have a median cost of $3.4M per trial — 40% of drug candidates fail.

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post AI’s moment in preclinical drug development arrives: Why formulation tech is the next frontier appeared first on CB Insights Research.

While AI copilots — which work alongside humans to speed up their workflows — currently comprise 90% of company activity, the tech will serve as a stepping stone to more autonomous solutions in the coming years. Eventually, AI agents could manage entire industrial processes, shifting human roles from operational tasks to strategic oversight.

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post The industrial AI agents & copilots market map appeared first on CB Insights Research.

Bringing a drug to market traditionally involves staggering costs — averaging $1.3B when accounting for all failed compounds — and costs continue to rise as productivity in the drug R&D process declines. 

AI has the potential to break this pattern by dramatically accelerating drug discovery and reducing costs.

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post Inside the AI drug discovery arms race: Record M&A activity, a biologics funding spree, and more appeared first on CB Insights Research.

Liquid biopsy tests also offer the ability to track treatment response, detect resistance early, and adjust therapy dynamically — advantages that could improve outcomes while reducing failed treatment costs.

As incumbents look to expand their footprint in oncology tech, there are several key shifts in the liquid biopsy landscape to watch:

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post The next big cancer tech acquisition could be one of these 5 liquid biopsy players appeared first on CB Insights Research.

More than 30 companies have emerged in the AI recruiting agents & copilot market, which leverage large language models (LLMs) to streamline time-consuming and repetitive recruiting tasks end-to-end.

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post The genAI recruiter is coming: How AI agents & copilots are making hiring more efficient and who to watch next appeared first on CB Insights Research.

The content below was curated by our experts using CBI Instant Insights, a one-click AI analysis and summarization tool. Click on company profiles for more details and sourcing information.

NOTABLE DEALS

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post This month in genAI: xAI raises $5B, Microsoft announces multi-agent system, Anthropic partners with Palantir and AWS appeared first on CB Insights Research.

Through M&A, leaders like PowerFleet and Element Fleet Management are layering on expanded capabilities that help fleet managers optimize for elements like charging schedules, battery range, autonomous routing efficiency, and maintenance cycles.  

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post Why fleet management leaders are racing to acquire next-gen telematics capabilities — and which M&A targets could be next appeared first on CB Insights Research.

Using CB Insights data, we uncovered 4 strategic priorities highlighted by Roche’s acquisitions, investments, and partnerships since Q1’23. We then categorized companies by their relationships with Roche across these priorities.

Here are 3 key takeaways from our analysis:

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post Roche targets two emerging battlegrounds — obesity and AI diagnostics — for its next growth phase appeared first on CB Insights Research.

In response, robotics companies are seeing an opportunity to deploy their solutions across the healthcare industry — from automated medication dispensing to robotics-assisted physical therapy. Broader interest in the space is also rising, with healthcare robotics news mentions reaching a new high in October.

Want to see more research? Join a demo of the CB Insights platform.

If you’re already a customer, log in here.

The post Robots are coming for healthcare — here are the emerging hotspots according to recent deals appeared first on CB Insights Research.